Fig. 2From: Expert consensus on the management of adverse events and prescribing practices associated with the treatment of patients taking pirfenidone for idiopathic pulmonary fibrosis: a Delphi consensus studyThe Likert scale used in the final stage of the Delphi process. For the following Delphi Consensus Figs. 3, 4, 5, 6, 7, 8, 9, 10, statements with a consensus for are bolded; statements with consensus against are shown with a grey backgroundBack to article page